Overview
Caesarean section is one of the most commonly performed surgical procedures worldwide and is associated with moderate-to-severe postoperative pain that can significantly impact recovery, patient satisfaction, breastfeeding success, and early mother–child bonding. Unlike most other procedures on this site, analgesic decisions here must also account for the needs of a second patient — the breastfeeding neonate — and the priority of early, unimpaired maternal mobility for newborn care.
PROSPECT 2026 summary (Crowe et al., updating Roofthooft 2021; 61 RCTs reviewed): For elective caesarean under neuraxial anaesthesia — intrathecal morphine 50–100 mcg or diamorphine 300 mcg pre-operatively, plus paracetamol, NSAIDs, and a single dose of IV dexamethasone after delivery. If neuraxial opioid is not used, a fascial plane block (TAP, ESP, or QL) or wound infiltration is recommended instead. Gabapentinoids are not recommended — a change reflecting new neutral trial evidence since the 2021 guideline.
Analgesic Pathway
- Intrathecal morphine 50–100 mcg or diamorphine 300 mcg — added to spinal anaesthesia
- Epidural morphine/diamorphine 2–3 mg — if CSE/epidural catheter in situ
- Spinal/CSE anaesthesia with intrathecal opioid as above
- Paracetamol 1g IV — after delivery
- NSAID — after delivery (e.g. diclofenac PR/IV)
- Dexamethasone single dose IV — after delivery
- TAP/ESP/QL block or wound infiltration — if no neuraxial opioid used
- Paracetamol 1g QDS regular
- NSAID regular ≤5 days
- Opioid PRN rescue — individualised/stratified prescribing
- Early mobilisation
- Post-discharge opioid stewardship — minimise take-home supply
✓ Recommended | ◎ Optional/conditional | ✗ Not recommended. Based on PROSPECT 2026 (Crowe et al.), elective CS under neuraxial anaesthesia.
Intrathecal Morphine — The Gold Standard
Intrathecal morphine (ITM) remains the gold standard for post-caesarean analgesia, providing 18–24h of effective analgesia from a single pre-operative dose added to the spinal injection. The 50–100 mcg dose range was reaffirmed unchanged in the 2026 update — no new evidence contradicted the established safety, effectiveness, or dosing.
| Agent | Dose | Route | Duration | Notes |
|---|---|---|---|---|
| Morphine | 50–100 mcg | Intrathecal (added to spinal) | 18–24h | Standard first-line choice |
| Diamorphine | 300 mcg | Intrathecal | 12–18h | Alternative; widely used in UK practice |
| Morphine | 2–3 mg | Epidural | 12–18h | Alternative when CSE/epidural catheter used |
| Diamorphine | 2–3 mg | Epidural | 12–18h | Alternative when CSE/epidural catheter used |
Monitor for delayed respiratory depression — peak risk typically 6–12h post-administration with intrathecal morphine. Standard practice includes hourly respiratory rate/sedation observations for at least 12–24h on the postnatal ward. Pruritus and PONV are common but generally manageable side effects; counsel patients accordingly.
Systemic Analgesia
| Agent | Dose | Route | Timing | Notes |
|---|---|---|---|---|
| Paracetamol | 1 g | IV/PO | After delivery, then QDS | Regular, foundational |
| Diclofenac | 75–100 mg | PR/IV | After delivery, then regular | Common choice; check renal function/pre-eclampsia status |
| Ibuprofen | 400 mg | PO | After delivery, then TDS | Alternative NSAID |
| Dexamethasone | Single dose | IV | After delivery | Recommended in the 2026 update — analgesic + antiemetic benefit; give after cord clamping |
| Oxycodone | 5–10 mg | PO PRN | 4–6h | Rescue only; individualise discharge quantity |
PROSPECT 2026 specifically calls for individualised or stratified post-discharge opioid prescribing — avoiding blanket large opioid quantities at discharge, and instead tailoring the take-home supply to each patient's anticipated need, in line with broader opioid stewardship efforts across surgical specialties.
When Intrathecal Morphine Is Not Used
For patients in whom ITM is contraindicated, declined, or not administered (e.g. general anaesthesia for caesarean, severe opioid sensitivity), fascial plane blocks or wound infiltration are the recommended alternative — but the choice among them matters.
QL block emerges as the closest alternative to ITM. A systematic review and meta-analysis directly comparing fascial plane blocks against ITM found that quadratus lumborum (QL) block — but not ESP or TAP block — achieved equivalent analgesic effect to ITM, while reducing opioid-related side effects (pruritus, nausea). TAP and ESP blocks remain reasonable options but with a less favourable comparative profile against the ITM benchmark specifically.
Comparative Summary
| Technique | vs ITM | Key finding |
|---|---|---|
| QL Block (posterior) | Equivalent analgesia | Best alternative when ITM not used; reduced opioid side effects vs ITM |
| TAP Block | Similar pain scores, less opioid-sparing | Equivalent to ITM on pain scores; less PONV than ITM; ITM superior for opioid consumption reduction |
| ESP Block | Less favourable than QL | Reasonable option but not the preferred alternative per comparative meta-analysis |
| Wound infiltration | Modest effect | Simple, low-risk option when blocks unavailable |
Dosing — QL Block (Posterior Approach)
| Agent | Concentration | Volume (per side) | Notes |
|---|---|---|---|
| Bupivacaine | 0.25% | 20–25 mL | Bilateral; calculate total dose |
| Ropivacaine | 0.2–0.375% | 20 mL | Bilateral; alternative agent |
Dosing — TAP Block
See the full TAP block page for technique. For caesarean section, bilateral lateral TAP is standard: ropivacaine 0.375% or bupivacaine 0.25%, 15–20 mL per side.
Breastfeeding & Opioid Stewardship
Analgesic choices after caesarean section should support, not hinder, maternal recovery and infant feeding:
- Paracetamol and NSAIDs are compatible with breastfeeding and form the safe foundation of the regimen
- Opioids pass into breast milk in small amounts; short-acting agents at the lowest effective dose for the shortest duration are preferred. Codeine and tramadol carry specific concern due to variable maternal CYP2D6 metabolism (ultra-rapid metabolisers risk neonatal opioid toxicity) — many guidelines now advise avoiding codeine in breastfeeding mothers
- Regional/neuraxial techniques (ITM, TAP, QL, ESP) minimise systemic opioid exposure, indirectly supporting breastfeeding by reducing maternal sedation and infant drug exposure
- Opioid-sparing discharge prescribing — explicitly recommended by PROSPECT 2026 — reduces both the volume of unused opioid in the community and infant exposure via milk during the recovery period
Not Recommended
A rigorous neutral trial specifically in patients with severe acute post-caesarean pain (randomised to gabapentin vs placebo, all receiving regular basic analgesia + neuraxial morphine) found no difference in pain scores, opioid consumption, or time to opioid cessation. This represents a change from earlier, more permissive positions — gabapentinoids are not recommended for caesarean section in the 2026 update.
Intrathecal or epidural buprenorphine, hydromorphone, midazolam, α2-agonists, neostigmine, and ketamine have all been reported to prolong neuraxial morphine's analgesic duration in individual studies, but cannot be recommended due to inconsistent procedure-specific evidence and potential side effects (hypotension, sedation).
Practical Analgesic Protocol
Suggested protocol for elective caesarean section under spinal anaesthesia:
References
- Crowe S, et al; PROSPECT Working Group. Pain management after elective caesarean section under neuraxial anaesthesia: an updated systematic review and PROSPECT recommendations. Anaesthesia. 2026. DOI 10.1111/anae.70141 ↗
- Roofthooft E, Joshi GP, Rawal N, Van de Velde M; PROSPECT Working Group. PROSPECT guideline for elective caesarean section: updated systematic review and procedure-specific postoperative pain management recommendations. Anaesthesia. 2021;76:665–680. DOI 10.1111/anae.15339 ↗
- The analgesic effects of novel fascial plane blocks compared with intrathecal morphine after Caesarean delivery: a systematic review and meta-analysis. Br J Anaesth. 2025. BJA ↗
- Postoperative Cesarean Section Pain Management Using TAP Block Versus Intrathecal Morphine: Systematic Review and Meta-analysis. J Perianesth Nurs. 2024. JoPAN ↗
- Intrathecal morphine vs ultrasound-guided bilateral posterior quadratus lumborum block in caesarean delivery. PMC. PMC11887214 ↗
- Analgesia after cesarean section – what is new? PMC. PMC10609703 ↗